biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > New article

<< Previous

Bullboard Posts

Next >>

Comment by chrispion Jul 09, 2021 11:09am

137 Views

Post# 33521103

RE:RE:New article

MineDigger wrote:
but no need to wate time clicking as no further info is provided, the article is just a rewrite of the MS NR.

Please Chrispi, evryone here knows everything in that article, we've got better things to do than reread the same information.

And that article https://themarketherald.ca/bioasis-announces-positive-results-from-an-efficacy-study-of-xb3tm-il-1ra-in-a-model-of-multiple-sclerosis-2021-07-07/ , although not giving additional scientific data, does an excellent job of summarizing the original press release, offering background info about the company and study that was not in the PR, and doing it in an easy-to-understand way for non-biotech people.
For those with no or little biotech background, I think the article gives a great perspective on the study!

Thanks for your great and helpful insight MD - did you even read the article?

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta